[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Evidence-Based Dermatology: Research Commentary
March 2004

A Randomized Controlled Trial of Methotrexate and Cyclosporine in the Treatment of Psoriasis

Arch Dermatol. 2004;140(3):347-348. doi:10.1001/archderm.140.3.347

Commentary on: Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis

Heydendael VM, Spuls PI, Opmeer BC, et al

N Engl J Med. 2003;349:658-665

Question: In patients with chronic plaque psoriasis, does treatment with cyclosporine or methotrexate lead to higher rates of clearance,and what toxic effects are associated with each treatment?

Design: Heydendael and colleagues conducted a randomized controlledtrial comparing the effectiveness and side effects of methotrexate and cyclosporineand the quality of life they provide.

First Page Preview View Large
First page PDF preview
First page PDF preview
×